Rhoda Eniafe

656 citations

18 papers · 529 indexed · h-index 12

Co-authors: Bipin N. Savani A. John Barrett Agnes S. M. Yong Katayoun Rezvani Stephan Mielke Keyvan Keyvanfar Roger Kurlander Behnam Jafarpour
Topics: Chronic Myeloid Leukemia Treatments (7 papers)T-cell and B-cell Immunology (6 papers)Acute Myeloid Leukemia Research (5 papers)
Cited by: Hematology Immunology Genetics
Journals: Blood British Journal of Haematology Leukemia
Partner nations: United States United Kingdom Germany

In The Last Decade

Rhoda Eniafe

18 papers receiving 520 citations

Peers

Countries citing papers authored by Rhoda Eniafe

Since Specialization

Citations

This map shows the geographic impact of Rhoda Eniafe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhoda Eniafe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhoda Eniafe more than expected).

Fields of papers citing papers by Rhoda Eniafe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhoda Eniafe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhoda Eniafe. The network helps show where Rhoda Eniafe may publish in the future.

Co-authorship network of co-authors of Rhoda Eniafe

This figure shows the co-authorship network connecting the top 25 collaborators of Rhoda Eniafe. A scholar is included among the top collaborators of Rhoda Eniafe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhoda Eniafe. Rhoda Eniafe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Effect of 5-[¹²⁵I]iodo-2′-deoxyuridine uptake on the proliferation and pluripotency of human embryonic stem cells 2012 ·International Journal of Radiation Biology ·Irina V. Panyutin,Rhoda Eniafe,(unknown),(unknown),Ronald D. Neumann	2
2	Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein 2011 ·Leukemia ·Agnes S. M. Yong,(unknown),Gerrit Weber,(unknown),Bipin N. Savani,Rhoda Eniafe,Keyvan Keyvanfar,Roger Kurlander,Katayoun Rezvani,A. John Barrett	25
3	Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy 2011 ·Cancer Immunology Immunotherapy ·Katayoun Rezvani,Agnes S. M. Yong,Stephan Mielke,Bipin N. Savani,Behnam Jafarpour,Rhoda Eniafe,Robert Q. Le,(unknown),(unknown),Richard Childs,A. John Barrett	13
4	Donor KIR Genes 2DL5A, 2DS1 and 3DS1 Are Associated with a Reduced Rate of Leukemia Relapse After HLA-Identical Sibling Stem Cell Transplantation for Acute Myeloid Leukemia but Not Other Hematologic Malignancies 2010 ·Biology of Blood and Marrow Transplantation ·Kate Stringaris,Sharon Adams,(unknown),Rhoda Eniafe,Colin O. Wu,Bipin N. Savani,A. John Barrett	66
5	Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8+ T cells in myeloid malignancies 2010 ·Haematologica ·Katy Rezvani,Agnes S. M. Yong,Stephan Mielke,Behnam Jafarpour,Bipin N. Savani,(unknown),Rhoda Eniafe,(unknown),(unknown),Roger Kurlander,A. John Barrett	98
6	In Chronic Myeloid Leukemia Cytotoxic T Cell Responses to BMI-1 Protein Correlate with Higher Expression of BMI-1 in Leukemia Progenitors, and May Contribute to Improved Outcome After Allogeneic Stem Cell Transplantation. 2009 ·Blood ·(unknown),Melanie R. Nicol,Bipin N. Savani,Yixin Li,Rhoda Eniafe,Keyvan Keyvanfar,Roger Kurlander,Katayoun Rezvani,A. John Barrett	1
7	Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy 2008 ·Leukemia ·Agnes S. M. Yong,Keyvan Keyvanfar,Rhoda Eniafe,Bipin N. Savani,Katayoun Rezvani,Elaine M. Sloand,J M Goldman,A. John Barrett	41
8	Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomib 2008 ·Blood ·Agnes S. M. Yong,Keyvan Keyvanfar,Nancy F. Hensel,Rhoda Eniafe,Bipin N. Savani,Maria Berg,Andreas Lundqvist,Sharon Adams,Elaine M. Sloand,John M. Goldman,Richard Childs,A. John Barrett	50
9	Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia 2008 ·Blood ·Katayoun Rezvani,Agnes S. M. Yong,Abdul Tawab,Behnam Jafarpour,Rhoda Eniafe,Stephan Mielke,Bipin N. Savani,Keyvan Keyvanfar,Yixin Li,Roger Kurlander,A. John Barrett	98
10	348: Human Neutrophil Elastase Stimulating CD4+ and CD8+ T Cells is a Potential Protein Vaccine for Leukemia Patients with Diverse HLA Types 2008 ·Biology of Blood and Marrow Transplantation ·Quang A. Le,(unknown),(unknown),Rhoda Eniafe,(unknown)	1
11	The Level of Minimal Residual Disease in Primitive Progenitor Cells from CML Patients after Allogeneic Stem Cell Transplantation Is Higher Than after Treatment with Tyrosine Kinase Inhibitors. 2008 ·Blood ·Agnes S. M. Yong,Keyvan Keyvanfar,Rhoda Eniafe,Bipin N. Savani,Katayoun Rezvani,Aarthi Shenoy,(unknown),(unknown),(unknown),Quan Le,John M. Goldman,A. John Barrett	7
12	High PR3 or ELA2 expression by CD34+ cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide–driven graft-versus-leukemia effects 2007 ·Blood ·Agnes S. M. Yong,Katayoun Rezvani,Bipin N. Savani,Rhoda Eniafe,Stephan Mielke,John M. Goldman,A. John Barrett	30
13	Human Neutrophil Elastase Stimulating CD4+ and CD8+ T Cells Is a Potential Protein Vaccine for Leukemia Patients with Diverse HLA Types. 2007 ·Blood ·Quan Le,J. Joseph Melenhorst,Nancy F. Hensel,Rhoda Eniafe,A. John Barrett	1
14	Hematopoietic Stem Cells and Primitive Progenitors Express Leukemia-Associated Antigens That May Be Targets for Graft-Versus-Leukemia Effect or for Vaccine-Based Immunotherapy in Chronic Myeloid Leukemia. 2006 ·Blood ·Agnes S. M. Yong,Keyvan Keyvanfar,Rhoda Eniafe,Bipin N. Savani,Elaine M. Sloand,John M. Goldman,A. John Barrett	2
15	Tissue-restricted T cell alloresponses across HLA barriers: selection and identification of leukemia-restricted CTL in HLA-mismatched stimulator–responder pairs 2003 ·Bone Marrow Transplantation ·Hiroshi Fujiwara,Giuseppe Sconocchia,J. Joseph Melenhorst,Rhoda Eniafe,Ryotaro Nakamura,Nancy F. Hensel,A. John Barrett	11
16	T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57 2003 ·The Hematology Journal ·J. Joseph Melenhorst,Rhoda Eniafe,Dean Follmann,Jeffrey J. Molldrem,Martha Kirby,Frank El Ouriaghli,A. John Barrett	27
17	Flow cytometric quantitation and characterization of the T-lymphocyte memory response to CMV in healthy donors 2002 ·Cytotherapy ·Nancy F. Hensel,(unknown),Ken Bradstock,Anthony P. Schwarer,Rhoda Eniafe,Ryotaro Nakamura,A. John Barrett	18
18	Molecular and flow cytometric characterization of the CD4 and CD8 T‐cell repertoire in patients with myelodysplastic syndrome 2002 ·British Journal of Haematology ·J. Joseph Melenhorst,Rhoda Eniafe,Dean Follmann,Ryô Nakamura,Martha Kirby,A. John Barrett	38

About Rhoda Eniafe

Rhoda Eniafe is a scholar working on Hematology, Immunology and Genetics, having authored 18 papers that have together received 529 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (7 papers), T-cell and B-cell Immunology (6 papers) and Acute Myeloid Leukemia Research (5 papers). The work is most often cited by research in Hematology (268 citations), Immunology (339 citations) and Genetics (89 citations). Rhoda Eniafe has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Bipin N. Savani, A. John Barrett, Agnes S. M. Yong, Katayoun Rezvani, A. John Barrett, Stephan Mielke, Keyvan Keyvanfar, Roger Kurlander, Behnam Jafarpour and Sharon Adams. Their work appears in journals such as Blood, British Journal of Haematology and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact